Shelter Pharma Ltd

Shelter Pharma Other Announcement

Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.

Shelter Pharma H1 FY27 Results: Net Profit ₹5.2 Cr, Up 15.6% YoY

Shelter Pharma Ltd reported revenue from operations of ₹45.1 Cr (+35.4% YoY) and net profit of ₹5.2 Cr (+15.6% YoY) for H1 FY27.

Key figure

Net profit ₹5.2 Cr · +15.6% YoY

Shelter Pharma Board Meeting Date

Shelter Pharma intimated its Board meeting is scheduled for November 7, 2026, to approve H1 FY27 unaudited results. Trading window remains closed until November 9, 2026.

Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C

Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.

Value

₹0.22 Cr

From

First Vet Veterinary Medicines Trading L.L.C

Execution

Within the mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹0.1 Cr Order from Genet International

Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.

Value

₹0.10 Cr

From

Genet International

Execution

Within mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.

Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.

Value

₹3.15 Cr

From

Taha Drugs & Chemicals Co. Ltd.

Execution

Within mutually agreed timelines as per purchase order schedule

Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...

Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.

Value

₹3.47 Cr

From

Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International

Execution

As per mutually agreed purchase order schedules

Shelter Pharma Other Announcement

Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.

Shelter Pharma Preferential Issue

Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.

Value

₹1.96 Cr

Shelter Pharma Convertible Warrants

Shelter Pharma Limited approved the conversion of 465,000 warrants into equity shares for its promoter. This allotment follows the receipt of the remaining exercise price of Rs. 1.47 Crore.

Value

₹1.47 Cr